Nuclear drug delivery for cancer chemotherapy
- 30 October 2011
- journal article
- review article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 155 (2), 227-236
- https://doi.org/10.1016/j.jconrel.2011.07.041
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophagesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for CancerAnnals of Biomedical Engineering, 2011
- HPMA copolymers: Origins, early developments, present, and futureAdvanced Drug Delivery Reviews, 2010
- The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistanceBiomaterials, 2010
- Dendrimer-based tumor cell targeting of fibroblast growth factor-1Bioorganic & Medicinal Chemistry Letters, 2010
- Folate‐mediated cell uptake of shell‐crosslinked spheres and cylindersJournal of Polymer Science Part A: Polymer Chemistry, 2008
- Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiersJournal of Controlled Release, 2008
- Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticlesJournal of Controlled Release, 2008
- Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell linesEuropean Journal of Pharmaceutical Sciences, 2007
- TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumorsJournal of Controlled Release, 2007